Top-News
Mittwoch,
07.11.2018 22:05
von
PR Newswire
| Aufrufe: 88
DaVita Inc. 3rd Quarter 2018 Results
Eine Labormitarbeiterin bei einer mikroskopischen Untersuchung. (Symbolbild)
© Likoper / iStock / Getty Images Plus / Getty Images
http://www.gettyimages.de/
PR Newswire
DENVER, Nov. 7, 2018
DENVER, Nov. 7, 2018 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2018.
Third quarter 2018 financial results - from continuing operations:
- Consolidated revenues of $2,847 million.
- Operating income of $289 million, including notable charges totaling $93 million.
- Cash flow of $362 million and free cash flow of $226 million.
| Net income (loss): | Three months ended September 30, | | Nine months ended September 30, | |||||||||||||
| | | 2018 | | 2017 | | 2018 | | 2017 | ||||||||
| | | (dollars in millions, except per share data) | ||||||||||||||
| | Attributable to DaVita Inc.: | | | | | | | | ||||||||
| | Net income from continuing operations | $ | 73 | | | $ | 153 | | | $ | 464 | | | $ | 745 | |
| | Per share | $ | 0.44 | | | $ | 0.80 | | | $ | 2.66 | | | $ | 3.85 | |
| | Adjusted net income from continuing operations(1) | $ | 93 | | | $ | 162 | | | $ | 467 | | | $ | 465 | |
| | Per share adjusted(1) | $ | 0.56 | | | $ | 0.85 | | | $ | 2.68 | | | $ | 2.40 | |
| | Net (loss) income | $ | (137) | | | $ | (214) | | | $ | 309 | | | $ | 360 | |
| | Per share | $ | (0.82) | | | $ | (1.12) | | | $ | 1.77 | | | $ | 1.86 | |
| | | | | |||||||||||||
| Operating income: | Three months ended September 30, | | Nine months ended September 30, | |||||||||||||
| | | 2018 | | 2017 | | 2018 | | 2017 | ||||||||
| | | (dollars in millions) | ||||||||||||||
| | Operating income | $ | 289 | | | $ | 395 | | | $ | 1,138 | | | $ | 1,662 | |
| | Adjusted operating income(1) | $ | 314 | | | $ | 404 | | | $ | 1,143 | | | $ | 1,185 | |
| ____________________ | |
| (1) | For the definitions of non-GAAP financial measures such as adjusted net income from continuing operations attributable to DaVita Inc., see the note titled "Note on Non-GAAP Financial Measures" below. |
Current items impacting operating income:
Advocacy costs: During the three months ended September 30, 2018, we incurred advocacy costs of $45 million in countering union policy efforts, including ballot initiatives. These costs are included in the U.S. dialysis and related lab services segment in general and administrative expenses.
Equity compensation: During the third quarter of 2018, the Company adopted a retirement policy which applies to outstanding equity awards which resulted in additional stock-based compensation expense in the quarter of $23 million related to modification charges and net acceleration of expense. This expense is included in the corporate administrative support segment.
Werbung
Mehr Nachrichten zur DaVita Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
